These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17613006)

  • 21. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
    Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
    J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of C-CAM cell adhesion molecule in prostate carcinogenesis in a transgenic mouse model.
    Pu YS; Luo W; Lu HH; Greenberg NM; Lin SH; Gingrich JR
    J Urol; 1999 Sep; 162(3 Pt 1):892-6. PubMed ID: 10458403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OSU-HDAC42, a histone deacetylase inhibitor, blocks prostate tumor progression in the transgenic adenocarcinoma of the mouse prostate model.
    Sargeant AM; Rengel RC; Kulp SK; Klein RD; Clinton SK; Wang YC; Chen CS
    Cancer Res; 2008 May; 68(10):3999-4009. PubMed ID: 18483287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary feeding of dibenzoylmethane inhibits prostate cancer in transgenic adenocarcinoma of the mouse prostate model.
    Khor TO; Yu S; Barve A; Hao X; Hong JL; Lin W; Foster B; Huang MT; Newmark HL; Kong AN
    Cancer Res; 2009 Sep; 69(17):7096-102. PubMed ID: 19706764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of androgen-independent prostate cancer cell aggressiveness by FTY720: validating Runx2 as a potential antimetastatic drug screening platform.
    Chua CW; Chiu YT; Yuen HF; Chan KW; Man K; Wang X; Ling MT; Wong YC
    Clin Cancer Res; 2009 Jul; 15(13):4322-35. PubMed ID: 19509141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice.
    Raina K; Singh RP; Agarwal R; Agarwal C
    Cancer Res; 2007 Jun; 67(12):5976-82. PubMed ID: 17575168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse.
    Wechter WJ; Leipold DD; Murray ED; Quiggle D; McCracken JD; Barrios RS; Greenberg NM
    Cancer Res; 2000 Apr; 60(8):2203-8. PubMed ID: 10786685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory Effect of Orally Administered 5-Aminolevulinic Acid on Prostate Carcinogenesis in the FVB-Transgenic Adenocarcinoma of a Mouse Prostate (FVB-TRAMP) Model.
    Onishi K; Miyake M; Tatsumi Y; Hori S; Nakai Y; Onishi S; Iemura Y; Owari T; Itami Y; Iida K; Anai S; Tanaka N; Shimada K; Fujimoto K
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3743-3749. PubMed ID: 33369476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.
    Gupta S; Ahmad N; Marengo SR; MacLennan GT; Greenberg NM; Mukhtar H
    Cancer Res; 2000 Sep; 60(18):5125-33. PubMed ID: 11016639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth inhibitory and apoptotic effects of inositol hexaphosphate in transgenic adenocarcinoma of mouse prostate (TRAMP-C1) cells.
    Sharma G; Singh RP; Agarwal R
    Int J Oncol; 2003 Nov; 23(5):1413-8. PubMed ID: 14532984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective expression of myosin IC Isoform A in mouse and human cell lines and mouse prostate cancer tissues.
    Ihnatovych I; Sielski NL; Hofmann WA
    PLoS One; 2014; 9(9):e108609. PubMed ID: 25259793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enigmol: a novel sphingolipid analogue with anticancer activity against cancer cell lines and in vivo models for intestinal and prostate cancer.
    Symolon H; Bushnev A; Peng Q; Ramaraju H; Mays SG; Allegood JC; Pruett ST; Sullards MC; Dillehay DL; Liotta DC; Merrill AH
    Mol Cancer Ther; 2011 Apr; 10(4):648-57. PubMed ID: 21398423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MT1G hypermethylation is associated with higher tumor stage in prostate cancer.
    Henrique R; Jerónimo C; Hoque MO; Nomoto S; Carvalho AL; Costa VL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1274-8. PubMed ID: 15894685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit.
    Wang L; Bonorden MJ; Li GX; Lee HJ; Hu H; Zhang Y; Liao JD; Cleary MP; Lü J
    Cancer Prev Res (Phila); 2009 May; 2(5):484-95. PubMed ID: 19401524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6.
    Garcia GE; Wisniewski HG; Lucia MS; Arevalo N; Slaga TJ; Kraft SL; Strange R; Kumar AP
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):980-8. PubMed ID: 16467113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression signatures associated with suppression of TRAMP prostate carcinogenesis by a kavalactone-rich Kava fraction.
    Tang SN; Zhang J; Jiang P; Datta P; Leitzman P; O'Sullivan MG; Jiang C; Xing C; Lü J
    Mol Carcinog; 2016 Dec; 55(12):2291-2303. PubMed ID: 26840761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia.
    Lotan TL; Lyon M; Huo D; Taxy JB; Brendler C; Foster BA; Stadler W; Rinker-Schaeffer CW
    J Pathol; 2007 Aug; 212(4):386-94. PubMed ID: 17577251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-inflammatory therapies in TRAMP mice: delay in PCa progression.
    Kido LA; Montico F; Sauce R; Macedo AB; Minatel E; Costa DB; Carvalho JE; Pilli RA; Cagnon VH
    Endocr Relat Cancer; 2016 Apr; 23(4):235-50. PubMed ID: 26772819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.